1. Home
  2. AYTU vs SELX Comparison

AYTU vs SELX Comparison

Compare AYTU & SELX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AYTU
  • SELX
  • Stock Information
  • Founded
  • AYTU N/A
  • SELX 2021
  • Country
  • AYTU United States
  • SELX Taiwan
  • Employees
  • AYTU N/A
  • SELX N/A
  • Industry
  • AYTU Biotechnology: Pharmaceutical Preparations
  • SELX
  • Sector
  • AYTU Health Care
  • SELX
  • Exchange
  • AYTU Nasdaq
  • SELX Nasdaq
  • Market Cap
  • AYTU 23.0M
  • SELX 24.7M
  • IPO Year
  • AYTU N/A
  • SELX N/A
  • Fundamental
  • Price
  • AYTU $2.19
  • SELX $0.85
  • Analyst Decision
  • AYTU Strong Buy
  • SELX
  • Analyst Count
  • AYTU 3
  • SELX 0
  • Target Price
  • AYTU $9.17
  • SELX N/A
  • AVG Volume (30 Days)
  • AYTU 182.8K
  • SELX 31.7K
  • Earning Date
  • AYTU 11-13-2025
  • SELX 01-01-0001
  • Dividend Yield
  • AYTU N/A
  • SELX N/A
  • EPS Growth
  • AYTU N/A
  • SELX N/A
  • EPS
  • AYTU N/A
  • SELX N/A
  • Revenue
  • AYTU $66,382,000.00
  • SELX $1,040,571.00
  • Revenue This Year
  • AYTU N/A
  • SELX N/A
  • Revenue Next Year
  • AYTU $29.12
  • SELX N/A
  • P/E Ratio
  • AYTU N/A
  • SELX N/A
  • Revenue Growth
  • AYTU 1.84
  • SELX N/A
  • 52 Week Low
  • AYTU $0.95
  • SELX $0.55
  • 52 Week High
  • AYTU $2.82
  • SELX $1.85
  • Technical
  • Relative Strength Index (RSI)
  • AYTU 46.28
  • SELX 42.71
  • Support Level
  • AYTU $2.23
  • SELX $0.55
  • Resistance Level
  • AYTU $2.31
  • SELX $0.95
  • Average True Range (ATR)
  • AYTU 0.12
  • SELX 0.12
  • MACD
  • AYTU -0.02
  • SELX -0.01
  • Stochastic Oscillator
  • AYTU 14.04
  • SELX 50.98

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.

About SELX Semilux International Ltd. Ordinary Shares

Semilux International Ltd is a company that operates through its subsidiaries which is an optical and 3D sensing technology company that is involved in the customization, design and supply of optical components and integrated chip for various industries including autonomous driving, intelligent lighting, as well as unmanned aerial vehicles. In collaboration with its clients, TCO conceptualizes and produces high precision optics and sensing modules that are specifically customized to clients' needs for ease of integration in overall design and production. Applications for TCO's products include automotive laser headlight systems, adaptive driving beams (ADB) as well as light detection and autonomous driving systems (LiDAR).

Share on Social Networks: